April 2022: Fc Receptor and IgG Targeted Therapies Conference
Development of STAR-0215: PKPD Model of STAR-0215, an Engineered IgG1 Monoclonal Antibody Targeting Plasma Kallikrein for the Prevention of HAE
February 2022: AAAAI Annual Meeting
STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor in Development for Treatment of HAE
Nov. 2021: ACAAI Annual Scientific Meeting
STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for the Potential Treatment of HAE
Oct. 2021: NORD Summit
Burdens of Disease and Treatment in Hereditary Angioedema: Interview Insights from HAE Patients
